Thoracic Neuromodulation for Diabetic Gastroparesis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Thoracic Neuromodulation for Diabetic Gastroparesis — Stella

Home/Diabetic Gastroparesis/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Gastroparesis trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Augusta University, Augusta, Georgia

Key details

Phase

Early testing

Sponsor

Medical University of South Carolina

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)

Enrollment target

~48 participants

Started

July 2022

Primary completion

May 2026

Age range

18 Years – 85 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.